Search results
Results from the WOW.Com Content Network
CytRx Corp. is a biopharmaceutical research and development oncology company based in Los Angeles, California. The CytRx oncology pipeline includes clinical trials involving their lead drug aldoxorubicin. Aldoxorubicin (formerly INNO-206) is a modified form of doxorubicin, the popular anthracycline chemotherapeutic agent known as "red death".
Abraxis BioScience was a global biopharmaceutical, and nano-medicine company that developed treatments for critically ill patients. It had over 2000 employees worldwide in 2007. [ 3 ] Abraxis's portfolio included the world's first protein-based nanoparticle chemotherapeutic compound , called nab Technology. [ 4 ]
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. [2] This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. [2]
Get the Los Angeles, CA local weather forecast by the hour and the next 10 days. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to reach us ...
The National Weather Service issued high surf advisories Thursday morning for Northern California, with 20-to-30-foot waves expected through Sunday. Associated Press 1 hour ago
Company Industry City Activision Blizzard: video games: Santa Monica [1] A-Mark Precious Metals: precious metals trading: Big 5 Sporting Goods: sporting goods: Capital Group Companies: financial services: Delta Scientific: defense & security: Deluxe Entertainment Services Group: entertainment: Dine Brands Global: restaurants: Dollar Shave Club ...
Dr. Tasneen Bhatia, better known as Dr. Taz, an integrative medicine physician and wellness expert, offers compounded GLP-1 to clients at her Los Angeles office, where she estimates about 10% to ...
Probitas Pharma, S.A. was incorporated with high limited liability under Spanish law on 22 June 1987; on 27 June 2005 the company changed its name to Grifols, S.A. [7] [self-published source] In 2003 the company acquired certain assets of the Los Angeles–based Alpha Therapeutic (US subsidiary of Mitsubishi Pharma) as the basis of its American ...